artificial intelligence
The UAE-based group has recruited Automation Anywhere to provide AI-powered software bots to “modernise key touch points”.
The AI-integrated software can be used for early detection of COVID-19 and other diseases through imaging biomarkers in Europe.
The AI medical software solution reportedly identifies abnormalities in body fluids and tissues, and is currently able to diagnose eight diseases, including rare genetic disorders.
The proceeds will be used to further develop its technology which transforms clinical text into data.
Microsoft Chief Medical Officer and VP of Healthcare Dr. David Rhew discusses how automation can help manage high patient call volumes, unwieldy medical device data and daily employee health screening.
The solution can be used to flag potential risks of COVID-19.
Group 42 and Oxford Nanopore Technologies have released details of a promising end-to-end solution that can mass screen for SARS-CoV-2.
The partnership aims to reduce pressure on the health system by automating the triage process.
insitro unveiled a $143 million Series B round on the same day that fellow machine learning company Exscientia highlighted its own $60 million Series C raise.